{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-26-000225","form_type":"8-K","ticker":"CTTH","cik":"0001035422","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","filed_at":"2026-08-12T11:30:23+00:00","discovered_at":"2026-08-12T11:35:00.282210+00:00","generated_at":"2026-08-12T11:35:13.770483+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CTT Pharma gets U.S. patent for nicotine, vitamin, caffeine delivery tech","bullets":["USPTO approved continuation-in-part patent for micelle delivery technology, effective Aug 11, 2026.","Patent covers nicotine, vitamins, and caffeine; enables dissolvable strips, gum, pouches, lozenges, and dissolving tablets.","Company states it will continue strengthening its patent portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-26-000225","json":"https://secwatch.observer/filing/0001171520-26-000225.json","markdown":"https://secwatch.observer/filing/0001171520-26-000225.md","text":"https://secwatch.observer/filing/0001171520-26-000225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/0001171520-26-000225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/eps12766_ctth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T11:35:13.770483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}